JDD Article Highlight JDDs article titled, Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists touches upon a significant increase in the use of GLP-1 agonists, like semaglutide and liraglutide, for weight loss has led to a rise in dermatologic adverse events, with over 6% of reported side effects being skin-related
Its a testament to the importance of specialized care and the tailored approach medicine has evolved to embrace
Incorporating Vitamin E-rich foods or supplements may be beneficial in supporting the treatment of IBD
doi: 10.1016/j.envres.2023.117027 64 GaoXSunLLiTZhangLLiJLiuYet al
These guides focus on clinical trial data, real-world insurance coverage, and practical considerations for patients
Those are different studies, and the readout makes the difference painfully obvious